Safety of cardiac pacemakers and ICDs in magnetic resonance imaging: Testing the functioning of these devices at 1.5 tesla;Sicherheit von herzschrittmachern und implantierbaren kardioverter- defibrillatoren im magnetresonanztomographen: Beurteilung der aggregatfunktion bei 1,5 tesla

Deutsche Medizinische Wochenschrift

Volumn 133, Issue 13, 2008, Pages 624-628

  Nordbeck, Peter ^a   Bauer, W R ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cardiac pacemaker functioning; Implantable cardioverter defibrillator; Magnetic field effects; Magnetic resonance imaging

Indexed keywords

ARTICLE; ARTIFICIAL HEART PACEMAKER; DEFIBRILLATOR; ELECTROMAGNETIC FIELD; HEART ARRHYTHMIA; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHANTOM; SAFETY; TACHYCARDIA; TREATMENT CONTRAINDICATION; DRUG CONTRAINDICATION; EQUIPMENT; IMAGE QUALITY; STANDARD;

ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; HUMANS; MAGNETIC RESONANCE IMAGING; PACEMAKER, ARTIFICIAL; PHANTOMS, IMAGING; SAFETY;

EID: 41049097491     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1067294     Document Type: Article

References (27)

1. Achenbach S, Moshage W, Diem B, Bieberle T, Schibgilla V, Bachmann K. Effects of magnetic resonance imaging on cardiac pacemakers and electrodes. Am Heart J 1997; 134 (3): 467-73
2. American Society for Testing and Materials (ASTM). Standard test method for measurement of radio frequency induced heating near passive implants during magnetic resonance imaging (F2182-02a). West Conshohocken, PA: ASTM International, 2004
3. Anfinsen OG, Berntsen RF, Aass H, Kongsgaard E, Amlie JP. Implantable cardioverter defibrillator dysfunction during and after magnetic resonance imaging. Pacing Clin Electrophysiol 2002; 25: 1400-2
4. Faris OP, Shein M. Food and Drug Administration perspective: Magnetic resonance imaging of pacemaker and implantable cardioverter- defibrillator patients. Circulation 2006; 114 (12): 1232-3
5. Ferris NJ, Kavnoudias H, Thiel C, Stuckey S. The 2005 Australian MRI safety survey. AJR Am J Roentgenol 2007; 188 (5): 1388-94
6. Fidler F, Nordbeck P, Warmuth M, Ehses P, Hiller KH, Weiss I, Maxfield M, Jakob PM, Bauer WR. MR-Safety: Investigation on a worst case implant heating protocol - a simple solution for radio frequency induced heating sequences. 18th International Conference of the Society for Medical Innovation and Technology SMIT. 11-14 May 2006, Monterey:
7. Food and Drug Administration, Medical device reporting http:// www.fda.gov/cdrh/mdr/
8. Gimbel JR, Kanal E, Schwartz KM, Wilkoff BL. Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICDs). Pacing Clin Electrophysiol 2005; 28 (4): 270-3
9. Gimbel JR, Wilkoff BL, Kanal E, Rozner MA. Safe, sensible, sagacious: responsible scanning of pacemaker patients. Eur Heart J 2005; 26 (16): 1683-4
10. Gimbel JR, Bailey SM, Tchou PJ, Ruggieri PM, Wilkoff BL. Strategies for the safe magnetic resonance imaging of pacemaker-dependent patients. Pacing Clin Electrophysiol 2005; 28 (10): 1041-6
11. Irnich W, Irnich B, Bartsch C, Stertmann WA, Gufler H, Weiler G. Do we need pacemakers resistant to magnetic resonance imaging? Europace 2005; 7 (4): 353-65
12. Levine GN, Gomes AS, Arai AE, Bluemke DA, Flamm SD, Kanal E, Manning WJ, Martin ET, Smith JM, Wilke N, Shellock FS American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Radiology and Intervention. Safety of magnetic resonance imaging in patients with cardiovascular devices. Circulation 2007; 116 ((24)): 2878-91
13. Luechinger R, Duru F, Scheidegger MB, Boesiger P, Candinas R. Force and torque effects of a 1.5-Tesla MRI scanner on cardiac pacemakers and ICDs. Pacing Clin Electrophysiol 2001 ((2)24: 199-205
14. Luechinger R, Duru F, Zeijlemaker VA, Scheidegger MB, Boesiger P, Candinas R. Pacemaker reed switch behavior in 0.5, 1.5, and 3.0 Tesla magnetic resonance imaging units: are reed switches always closed in strong magnetic fields? Pacing Clin Electrophysiol 2002; 25 ((10)): 1419-23
15. Luechinger R, Zeijlemaker VA, Pedersen EM, Mortensen P, Falk E, Duru F, Candinas R, Boesiger P. In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J 2005; 26 (4): 376-83
16. Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 2004; 43 ((7)): 1315-24
17. Martin ET. Can cardiac pacemakers and magnetic resonance imaging systems co-exist? Eur Heart J 2005; 26 (4): 325-7
18. Nath S, Lynch C3rd, Whayne JG, Haines DE. Cellular electrophysiological effects of hyperthermia on isolated guinea pig papillary muscle. Implications for catheter ablation. Circulation 1993; 88 ((4 Pt 1)): 1826-31
19. Nazarian S, Roguin A, Zviman MM, Lardo AC, Dickfeld TL, Calkins H, Weiss RG, Berger RD, Bluemke DA, Halperin HR. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation 2006; 114 ((12)): 1277-84
20. Nordbeck P, Fidler F, Weiss I, Warmuth M, Friedrich MT, Ehses P, Geistert W, Ritter O, Jakob PM, Ladd ME, Quick HH, Bauer WR. Spatial distribution of RF-induced E-fields and implant heating in MRI. Magn Reson Med Accepted
21. Rezai AR, Finelli D, Nyenhuis JA, Hrdlicka G, Tkach J, Sharan A, Rugieri P, Stypulkowski PH, Shellock FG. Neurostimulation systems for deep brain stimulation: in vitro evaluation of magnetic resonance imaging-related heating at 1.5 tesla. J Magn Reson Imaging 2002; 15 ((3)): 241-50
22. Roguin A, Zviman MM, Meininger GR, Rodrigues ER, Dickfeld TM, Bluemke DA, Lardo A, Berger RD, Calkins H, Halperin HR. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T Circulation 2004; 110 ((5)): 475-82
23. Shellock FG, Fieno DS, Thomson LJ, Talavage TM, Berman DS. Cardiac pacemaker: in vitro assessment at 1.5 T. Am Heart J 2006; 151 ((2)): 436-43
24. Sommer T, Vahlhaus C, Lauck G, von Smekal A, Reinke M, Hofer U, Block W, Traber F, Schneider C, Gieseke J, Jung W, Schild H. MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T. Radiology 2000; 215: 869-79
25. Sommer T, Naehle CP, Yang A, Zeijlemaker V, Hackenbroch M, Schmiedel A, Meyer C, Strach K, Skowasch D, Vahlhaus C, Litt H, Schild H:. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation 2006; 114 ((12)): 1285-92
26. Vahlhaus C, Sommer T, Lewalter T, Schimpf R, Schumacher B, Jung W, Lüderitz B. Interference with cardiac pacemakers by magnetic resonance imaging: are there irreversible changes at 0.5 Tesla? Pacing Clin Electrophysiol 2001; 24: 489-95
27. Wollmann C, Grude M, Tombach B, Kugel H, Heindel W, Breithardt G, Böcker D, Vahlhaus C. Safe performance of magnetic resonance imaging on a patient with an ICD. Pacing Clin Electrophysiol 2005; 28: 339-42